MedPath

Multi-center Ocular Biological Parameters Study

Conditions
Cataract
Registration Number
NCT04340635
Lead Sponsor
Aier School of Ophthalmology, Central South University
Brief Summary

This study is a multi-center study, which collects data from multiple regions to obtain the general biological characteristics of the Chinese population. The formula for calculating the artificial lens power based on foreign populations is effectively modified based on the Chinese population.

Detailed Description

①Relevant domestic studies on the biological characteristics of the eye are mainly limited to a certain city and region. Most of the studies that represent the biological characteristics of the general population in China and the differences in biological parameters at home and abroad are in the research process, or Semi-finished products.

②The investigators found in clinical observation that the eyeball biological data of the Chinese population may not be consistent with the foreign population.

③ This study is the first study of human eye biological parameters based on different regions of large-scale populations in China, which is of great significance for understanding the human eye structure in different regions of China.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20000
Inclusion Criteria
  • patients aged over 50 years
Exclusion Criteria
  • history of refractive surgery,
  • corneal diseases
  • ocular inflammation
  • trauma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
axial length (AL)1 hour

Measured using the partial coherence laser interferometry (IOLMaster, Carl Zeiss Meditec, Germany)

anterior chamber depth (ACD)1 hour

Measured using the partial coherence laser interferometry (IOLMaster, Carl Zeiss Meditec, Germany)

keratometric power (K)1 hour

Measured using the partial coherence laser interferometry (IOLMaster, Carl Zeiss Meditec, Germany)

corneal astigmatism (CA)1 hour

Measured using the partial coherence laser interferometry (IOLMaster, Carl Zeiss Meditec, Germany)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai Aier Eye Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath